Sage Professional Consulting Corporation Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: Two Saint Mark's Pl Ste 147, La Grange, TX 78945 Phone: 979-530-8246 |
News Archive
Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, for the development and commercialization of lead immuno-oncology drug candidate APG101 in China, Macao, and Hong Kong.
"Washington, D.C., is usually under the watchful eye of policy wonks and journalists. This weekend, however, the eyes of millions of children will be on D.C. as their fates are determined by the world's financial leaders, descending on Washington for the Spring Meetings of the IMF and World Bank," Ray Chambers, U.N. special envoy for health financing, writes in the Huffington Post's "Impact" blog.
The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets, according to a scientific paper by the Translational Genomics Research Institute published this month in the journal Molecular Cancer.
Envy Medical, Inc., introduces the new Lumixyl™ Brightening System, a revolutionary multi-faceted approach to effectively treat hyperpigmentation without irritation or other side effects associated with prescription Hydroquinone or retinoids. This professional skincare system introduction builds on the success of the Lumixyl Topical Brightening Creme introduced in 2009.
› Verified 3 days ago